Lensar (LNSR) Preferred Stock Liabilities (2019)
Lensar (LNSR) posted quarterly Preferred Stock Liabilities of $36.4 million for Q4 2019.
Lensar (LNSR) Preferred Stock Liabilities (2019) Analysis & Trends
Lensar (LNSR) has reported Preferred Stock Liabilities for 1 consecutive years, with $36.4 million the latest figure, recorded in Q4 2019.
- In Q4 2019, Preferred Stock Liabilities changed N/A year-over-year to $36.4 million; the TTM figure through Dec 2019 stood at $36.4 million (changed N/A YoY), while the FY2019 annual figure was $36.4 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $36.4 million in Q4 2019 per LNSR's latest filing.
- Across five years, Preferred Stock Liabilities topped out at $36.4 million in Q4 2019 and bottomed at $36.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Lensar | 103.79 Mn | 90.22 Mn | 9.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 36.42 Mn |